These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 25420320

  • 1. [A comparison of susceptibility of Pseudomonas aeruginosa clinical isolates to carbapenem antibiotics in our hospital].
    Kakeya H, Yamada K, Nakaie K, Takizawa E, Okada Y, Fujita A, Nakamura Y, Abe J, Hirose A, Kaneko Y, Hino M.
    Jpn J Antibiot; 2014 Aug; 67(4):241-8. PubMed ID: 25420320
    [Abstract] [Full Text] [Related]

  • 2. Correlation between meropenem and doripenem use density and the incidence of carbapenem-resistant Pseudomonas aeruginosa.
    Shigemi A, Matsumoto K, Yaji K, Shimodozono Y, Takeda Y, Miyanohara H, Kawamura H, Orita M, Tokuda K, Nishi J, Yamada K.
    Int J Antimicrob Agents; 2009 Dec; 34(6):589-91. PubMed ID: 19748231
    [Abstract] [Full Text] [Related]

  • 3. Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa: the high potency of a new carbapenem doripenem.
    Sakyo S, Tomita H, Tanimoto K, Fujimoto S, Ike Y.
    J Antibiot (Tokyo); 2006 Apr; 59(4):220-8. PubMed ID: 16830889
    [Abstract] [Full Text] [Related]

  • 4. [Comparative antibacterial activity of carbapenems against P. aeruginosa (1)].
    Hikida M, Terashima S, Sato Y, Okamoato R, Inoue M.
    Jpn J Antibiot; 2001 Nov; 54(11):571-9. PubMed ID: 11828603
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The Implementation of a Hospital-wide Practice for the Selective Use of Carbapenems Based on the Monitoring of Susceptibility of Pseudomonas aeruginosa Isolates.
    Ohshima T, Asai S, Miyazawa M, Yamamoto Y, Hisada A, Kumazawa C, Hashimoto M, Fukawa K, Iwashita H, Umezawa K, Yamada S, Yamamoto Y, Miyachi H.
    Tokai J Exp Clin Med; 2017 Dec 20; 42(4):176-181. PubMed ID: 29228415
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Antimicrobial activities of meropenem against clinically isolated strains in 1997].
    Suzuki Y, Matsumoto Y, Nishinari C, Endo H, Ishihara R, Deguchi K.
    Jpn J Antibiot; 1999 Dec 20; 52(12):695-720. PubMed ID: 10695025
    [Abstract] [Full Text] [Related]

  • 9. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated from urine at one hospital to mainly carbapenem and fluoroquinolone drugs].
    Watanabe Y, Fujiue Y, Yano S, Shimizu S, Muroki K, Doi M, Kuwabara M.
    Jpn J Antibiot; 2006 Apr 20; 59(2):65-71. PubMed ID: 16805317
    [Abstract] [Full Text] [Related]

  • 10. [Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid].
    Deguchi K, Koguchi M, Suzuki Y, Tanaka S, Fukayama S, Ishihara R, Oda S, Nakane Y, Fukumoto T.
    Jpn J Antibiot; 1996 Apr 20; 49(4):377-85. PubMed ID: 8786628
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.
    Valenza G, Seifert H, Decker-Burgard S, Laeuffer J, Morrissey I, Mutters R, COMPACT Germany Study Group.
    Int J Antimicrob Agents; 2012 Mar 20; 39(3):255-8. PubMed ID: 22230334
    [Abstract] [Full Text] [Related]

  • 13. Interpreting carbapenem susceptibility testing results for Pseudomonas aeruginosa.
    Micaëlo M, Brossier F, Bréchot N, Luyt CE, Lu Q, Monsel A, Jarlier V, Aubry A.
    Med Mal Infect; 2018 Aug 20; 48(5):365-371. PubMed ID: 29628176
    [Abstract] [Full Text] [Related]

  • 14. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
    Lee CH, Su TY, Ye JJ, Hsu PC, Kuo AJ, Chia JH, Lee MH.
    J Microbiol Immunol Infect; 2017 Oct 20; 50(5):677-683. PubMed ID: 26188977
    [Abstract] [Full Text] [Related]

  • 15. [Antimicrobial activities and mechanisms of carbapenem resistance in clinical isolates of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter spp].
    Sugino Y, Iinuma Y, Nada T, Tawada Y, Amano H, Nakamura T, Hasegawa Y, Shimokata K, Shibata N, Arakawa Y.
    Kansenshogaku Zasshi; 2001 Aug 20; 75(8):662-70. PubMed ID: 11558128
    [Abstract] [Full Text] [Related]

  • 16. Sensitivity surveillance of Pseudomonas aeruginosa isolates for several antibacterial agents in Chubu area (2013-2014).
    Kakumoto A, Okade H, Misuyama J, Yamaoka K, Asano Y, Matsukawa Y, Suematsu H, Sawamura H, Matsubara S, Shibata N, Watanabe K, Yamamoto Y, Iwasaki H, Yamagishi Y, Mikamo H, Chubu Anti-biogram Study Group.
    Jpn J Antibiot; 2016 Oct 20; 69(5):327-341. PubMed ID: 30226946
    [Abstract] [Full Text] [Related]

  • 17. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF, Liu CP, Wang NY, Shih SC.
    BMC Infect Dis; 2016 Aug 24; 16(1):444. PubMed ID: 27553962
    [Abstract] [Full Text] [Related]

  • 18. Effect of sodium mercaptoacetic acid on different antimicrobial disks in the sodium mercaptoacetic acid double disk synergy test for detection of IMP-1 metallo-β-lactamase-producing Pseudomonas aeruginosa isolates in Japan.
    Sakanashi D, Miyazaki N, Kawamoto Y, Ohno T, Yamada A, Koita I, Miyajima S, Suematsu H, Hagihara M, Asai N, Koizumi Y, Yamagishi Y, Mikamo H.
    J Infect Chemother; 2019 Jan 24; 25(1):75-77. PubMed ID: 30100401
    [Abstract] [Full Text] [Related]

  • 19. Carbapenem-Nonsusceptible Pseudomonas aeruginosa Isolates from Intensive Care Units in the United States: a Potential Role for New β-Lactam Combination Agents.
    Asempa TE, Nicolau DP, Kuti JL.
    J Clin Microbiol; 2019 Aug 24; 57(8):. PubMed ID: 31118271
    [Abstract] [Full Text] [Related]

  • 20. MIC score, a new tool to compare bacterial susceptibility to antibiotics application to the comparison of susceptibility to different penems of clinical strains of Pseudomonas aeruginosa.
    Bretonnière C, Maitte A, Caillon J, Potel G, Boutoille D, Jacqueline C, Guitton C.
    J Antibiot (Tokyo); 2016 Nov 24; 69(11):806-810. PubMed ID: 27025352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.